Table: Stemcell Institute -2025/26 group results
May 13 (Reuters)-
Stemcell Institute
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 2.81 3.10
(+10.3 pct)
Operating 202 mln 100 mln
(-50.7 pct)
Recurring 217 mln 100 mln
(-54.0 pct)
Net
Net 155 mln 105 mln
(-32.7 pct)
EPS 15.44 yen 10.32 yen
Ann Div NIL 25.00 yen NIL
-Q2 Div NIL 25.00 yen NIL
-Q4 Div NIL NIL NIL
NOTE - Stemcell Institute.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7096.T